Abstract: As part of the Pacific Program to Eliminate Lymphatic Filariasis (PacELF), baseline surveys were conducted in 1999 and 2004 in Nauru to determine the prevalence of filariasis by rapid immunochromatotraphic test (ICT). In 1999, the survey demonstrated a filariasis prevalence of 0.26%, and Nauru was classified as a nonendemic country at the time. In 2004, the prevalence resulting from the survey was 1.66%. Since it exceeded 1.0%, this high prevalence warranted the implementation of Mass Drug Administration (MDA) according to WHO guidelines and gave rise to an urgent need to re-establish the filariasis policy in Nauru, as the target year for filariasis elimination in the Pacific is 2010. The present study was conducted to determine the current prevalence of filariasis, to decide whether implementation of the MDA program is necessary, and to compare the demographic characteristics of participants according to the ICT test results. Blood sampling and interviews, based on a simple questionnaire asking about filariasis-related symptoms, were conducted by trained health staff members. A total of 1,513 people were enrolled for the survey in January 2007. Filariasis positivitiy was detected in three subjects (0.2%) by ICT test. Nauru was reconfirmed as a non-endemic country and therefore did not require the MDA implementation. The prevalence did not vary significantly according to the demographic characteristics. The three seropositive cases did not have any filariasis-related symptoms. However, two of the three positive cases of filariasis lived in the same district and the other lived in a neighboring district. To assess the interruption of filariasis transmission, further surveys are recommended.
INTRODUCTION
Lymphatic filariasis is recognized as a serious public health concern in view of its huge adverse effect on clinical morbidity and disability [1, 2, 3] . Consequently, global efforts are underway to eliminate lymphatic filariasis. The Pacific Program to Eliminate Lymphatic Filariasis (PacELF) was established in 1999 to eliminate filariasis in the Pacific region by 2010 through Mass Drug Administration (MDA). The primary strategy for the prevention of filariasis, MDA is based on providing anti-parasite drugs once a year for five years to the entire population at risk of developing filariasis. This strategy has contributed to a significant reduction of cases.
Nauru has been involved in two baseline surveys, one performed in 1999 and the other in 2004 by immunochromatographic test (ICT) ( Table 1 ) [4] . The 1999 survey involved 388 participants and detected one positive case (prevalence of 0.26%). Nauru was subsequently classified as a non-endemic country (PacELF, 2006; PacELF, 2004) . The 2004 survey involved 902 participants and detected 15 positive cases (prevalence of 1.66%). Since it exceeded 1.0%, this prevalence warranted the implementation of MDA according to the WHO guidelines for Filariasis Elimination. Moreover, six of the 15 positive cases (40%) were . This sudden increase from 1999 to 2004 indicated the occurrence of an endemic in limited districts of Nauru. Experiences in the hospital and communities, including the number of patients observed with elephantiasis, hydrocele and cellulitis, also suggested the existence of filariasis in Nauru. However, the blood samples used in the latter survey were collected, not for the filariasis baseline survey, but for surveillance of other non-communicable diseases and involved about 2,000 participants ranging in age from 15 to 64 years. Therefore, the filariasis baseline survey of 2004 contained uncertainty in measurement procedures, e.g., it was not known how the 902 subjects for the ICT test were selected from among the 2,000 participants in the noncommunicable disease surveillance. The study presented here was carried out in 2007 to determine the prevalence of filariasis in Nauru, to decide whether implementation of the MDA program was necessary, and to compare the characteristics of participants according to the ICT test results.
STUDY AREA AND TEST METHODS
The study was undertaken as a nationwide program over a period of three weeks in January 2007. Nauru is an island located at S0 32 E166 55 , approximately 41 km south of the equator, having a land area of 21 km 2 with 9,275 inhabitants as of 2006. Nauru consists of 15 districts: Yaren, Boe, Buada, Aiwo, Denigomodu (Denig), Location, Nibok, Uaboe, Baitsi, Ewa, Anetan, Anabar, Ijuw, Anibare and Menen.
Blood sampling by the rapid immunochromatographic test for the detection of Wuchereria bancrofti antigen (ICT, Lot No. 023766, 023767 , Binax Inc, USA) was performed and interpreted according to the manufacturer's instructions. Blood samples were taken by finger prick blood collection using a capillary. All ICT cards were assessed by trained health personnel exactly 10 minutes after samples were taken.
Questionnaires were designed so that the characteristics and trends of filariasis in Nauru could be compared between ICT negative and positive cases. The following types of data were collected by closed-end questions: (1) Demographic data, including sex, nationality, and age; and (2) participants' filariasis-related symptom data including existence of slight leg swelling, enlarged leg with folds, enlarged arm, enlarged breast, hydrocele, cellulitis, and recurrent cellulitis. Visual aids illustrating filariasis-related symptoms were utilized. However, visual inspection and clinical evaluation of symptoms were not achieved. Data collection was conducted by health personnel who underwent interviewer training for two days. The training material covered the biology and pathology of filariasis, related symptoms, survey methodology and procedure.
Sample size estimation was calculated and showed that at least 1,323 participants were required for the survey to obtain accurate results. A total of 1,500 samples were selected randomly by the Bureau of Statistics Office based on the database of the Household Income and Expenditure Survey in 2006 among a population of 9,275. Demographic data such as age and the population size of each district was taken into account for random sampling. Ultimately, 16.2% of the population was extracted as a sample from each district.
The criteria for participation in the study were residence in Nauru, age four years or over, and any ethnicity. ICT positive cases from previous studies were eligible for inclusion in this study. The only exclusion criteria were infants aged zero to three years. International organization representatives from foreign countries, mainly Australia, were also excluded from participation. In cases where participant numbers were insufficient, voluntary participants were accepted until the required sample number was achieved, as long as these volunteers met the selection criteria. Recruitment and appointment of participants was performed one day before the scheduled survey date for each district. On the following day, data collection was conducted at survey sites, as well as the dwellings of participants.
To ensure quality and completeness, the data was double checked at two stages. At the first stage, questionnaires were checked by the interviewers themselves, confirming that all coding boxes for each question were filled in completely. At the second stage, the project coordinator checked all the questionnaires and assigned serial numbers. Data were entered into the study database made by EpiData. The statistical analyses were performed with the statistical package SPSS 11.5 J for Windows.
Informed consent was obtained from the participants in the appointment process, but informed consent was not obtained from voluntary participants who came to the survey site directly without appointment. However, in all cases, special care was taken to keep private information confidential.
RESULTS
A total of 1,513 subjects, composed of 819 randomly selected participants (54.6% of randomly selected people and 54.1% of the examined subjects) and 694 voluntary participants (45.9% of the examined subjects), were tested with rapid diagnostic test kits (ICT) during the survey period (Figure 1 ). Participants were made up of 736 males (48.6%) and 777 females (51.4%). Nationality was 1,459 Nauruan (96.4%), 44 Gilbertese (2.9%), and 10 other nationalities (0.7%). To assess the representativeness of participants, the percentage of age distribution (Figure 2 ) and the percentage of area structure (Figure 3 ) between the examined subjects and total population of Nauru were compared, and the examined group in the current study was found to be representative of Nauru's total population.
Among the 1,513 examined subjects, filariasis positive cases were detected in three persons (0.2%). Table 2 briefly explains the information of each case, and Figure 4 shows the district of residence. Specimens from the three ICT positive cases were sent to the contract laboratory in Australia for microfilaria confirmation by microscopy, and the re- The third subject lives in Aiwo, which is adjacent to Boe.
Point prevalence of ICT positivity for all participants was 0.20% (95% CI of 0.03 to 0.42). The demographic characteristics were compared between the ICT negative cases (1,510 persons) and the three positive cases (Table 3) .
There were no significant differences between the two groups with regard to sex (p=0.595), nationality (p=0.739), or age (p=0.911). To simplify the analysis, the 15 districts were grouped into five regions following the national census classification based on the geographical distribution, and, again, prevalence did not differ significantly according to the resident districts (p=0.180).
Among the examined subjects, there were 56 (3.7%) with leg swelling, 11 (0.7%) with enlarged leg, 19 (1.3%) with arm swelling, 67 (4.4%) with cellulitis, and 263 (17.4%) with recurrent cellulitis. Among females, there were 13 (1.7%) with enlarged breast. Among males, there were 11 (1.5%) with hydrocele. The three seropositive cases did not have any filariasis-related symptoms.
DISCUSSION
The Ministry of Health of Nauru carried out a filariasis baseline survey as a nationwide program, using ICT test for filarial antigen detection and a simple questionnaire. The current study revealed that the filariasis prevalence was 0.20%, reconfirming Nauru as a non-endemic country. This prevalence can serve as the guiding principle for Nauru's filariasis policy in that it indicates no need to implement MDA in this case. However, Nauru still has concerns and potential causes of a filarial pandemic due to crowded living conditions, housing quality, and inadequate waste disposal management. Also, frequent migration between endemic countries such as Fiji, Kiribati, and the Marshall Islands can contribute to filariasis occurrence. Therefore, the Ministry of Health should closely monitor the incidence of filariasis in order to maintain the filariasis-free status of Nauru.
The prevalence found in this study (0.20%) was similar to that of the 1999 study (0.26%). However, the present study can be considered more accurate in view of the sample size (the 1999 and 2004 surveys included 388 and 902 people, respectively) and the ICT measurement method, because the assessment of results was performed strictly according to the manufacturer's instructions. Nevertheless, sampling bias could not be eliminated, even though the demographic characteristics of the examined subjects and total population were similar. Of 1,513 examined subjects in this survey, 819 (54.1%) were randomly selected participants and 694 (45.9%) were voluntary participants. It is difficult to predict the impact of such a large number of volunteer participants.
The 2004 Another interesting observation was the sudden decrease of prevalence in the Nibok district (from 8.3% to ,459  54  656  542  275  40  120  110  96  155  108  212  94  60  62  47  85  70  51  29  214 0.0%), given the number of participants from Nibok (94 subjects). The treatment of Albendazole and DEC for the six positive cases from 2004 may have been effective. On the other hand, several interviewers stated that they observed that results often turned positive after more than 10 minutes. Therefore, there was a possibility that the prevalence of the 2004 survey contained a number of false positive cases if some ICT cards were checked after more than 10 minutes.
To assess the trends of filariasis incidence, demographics factors were compared according to the ICT test results. No significant variations were observed between ICT negative and positive cases with regard to any category. Because the ICT positive cases were relatively rare (three persons or 0.20%), it was difficult to assess the trend of filariasis by means of statistic analysis.
Through the survey, some participants having chronic clinical filariasis were detected by questionnaire-based interview. However, it would seem that the data did not reflect accurate levels of filarial burden. This may be due to the fact that the survey was conducted using only a questionnaire-based interview, no clinical observations or evaluations being performed.
Questions regarding the association between filariasis and cellulitis have arisen in the hospital and affected communities, and this survey revealed a high prevalence of recurrent cellulitis (17.4%). However, the causes of cellulitis are not only lymphedema but also insect bite, aging, diabetes, and ulcers or fungal infections. The prevalence of cellulitis in Nauru is likely related to factors such as the high prevalence of diabetes in Nauru (16.2% in 15 to 64 year olds, 45.0% in 55 to 64 year olds) [5] . The current study suggested that cellulitis was very common among the people who exhibited filariasis-related symptoms, but this study could not verify whether cellulitis itself was associated with filariasis.
With regard to filariasis, Nauru was confirmed as a non -endemic country. However, there is a limit to the information available on ICT positive cases and on people who exhibited filariasis-related symptoms. Case studies and clinical inspections on these people as well as further studies in the Boe and Aiwo districts are recommended, since these two districts are adjacent. Moreover, to verify the interruption of filariasis transmission and to obtain national certification for filariasis elimination, further surveys focusing on five to six year old children must be undertaken before the end of the target year 2010.
